Xylem Raises 2024 Guidance: Now Expects Adj. EPS Of $4.10 To $4.25, (Prior $4.00-$4.20) Vs. $4.14 Est; Sales Guidance Of ~ $8.5B (Prior $8.4B-$8.5B) Vs. $8.505B Est.
Portfolio Pulse from Benzinga Newsdesk
Xylem has updated its 2024 financial guidance, raising its adjusted EPS forecast to $4.10-$4.25 from the previous $4.00-$4.20 and its sales guidance to approximately $8.5 billion from $8.4-$8.5 billion. The company now anticipates a 15-16% increase in reported revenue and a 4-6% increase on an organic basis, with an adjusted EBITDA margin of about 20.0%.
May 02, 2024 | 11:14 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Xylem raises its 2024 financial forecasts, including adjusted EPS to $4.10-$4.25 and sales to ~$8.5B, indicating stronger performance and growth expectations.
The upward revision in Xylem's financial guidance, especially the increase in adjusted EPS and sales forecasts, signals a positive outlook on the company's performance and growth. This is likely to be viewed favorably by investors, potentially leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100